Quantification of CD73 positive inflammatory cells revealed significant increases in Stage 4 COPD and Severe IPF patients compared to COPD and IPF patients with preserved lung function (Figure 5E). The gene discussed is NT5E; the disease is idiopathic pulmonary fibrosis.